MedTrace Logo

Perichondrium Autograft in Refractory Necrotizing Scleritis

NCT02864823 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-08-12

No results posted yet for this study

Summary

Necrotizing scleritis with severe ischemia is refractory to conventional treatment because of avascular necrosis.

The investigators assessed the therapeutic efficacy and safety of autologous perichondrium transplantation in patients with severe ischemic necrotizing scleritis, and analyzed the therapeutic effects.

Conditions

  • Necrotizing Scleritis

Interventions

PROCEDURE

Perichondrium Autografts

Perichondrium tissue was harvested from the patient's ear cartilage and transplanted to reconstruct the scleral defect.

Sponsors & Collaborators

  • Ministry of Science and ICT, Republic of Korea

    collaborator OTHER_GOV

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    lead OTHER

Principal Investigators

  • Jae Chan Kim, Ph.D. · Chung-Ang University Hosptial, Chung-Ang University College of Medicine

  • Jee Taek Kim, Ph.D. · Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864823 on ClinicalTrials.gov